Retinopathy of prematurity after sildenafil treatment

被引：3

作者：

Fuwa, Kazumasa ^{[1
]}

Hosono, Shigeharu ^{[1
]}

Nagano, Nobuhiko ^{[1
]}

Takahashi, Shori ^{[1
]}

Nakashima, Motohiro ^{[2
]}

机构：

[1] Nihon Univ, Sch Med, Dept Pediat & Child Hlth, Itabashi Ku, Oyaguchi 30-1, Tokyo 1738610, Japan

[2] Nihon Univ, Sch Med, Dept Visual Sci, Div Ophthalmol,Itabashi Ku, Tokyo, Japan

来源：

PEDIATRICS INTERNATIONAL | 2017年 / 59卷 / 03期

关键词：

oxygen; phosphodiesterase; 6; preterm infant; retinopathy of prematurity; sildenafil; ADULT-POPULATION; LYMPHOMA; CHILDREN;

D O I：

10.1111/ped.13187

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Sildenafil (SIL) is used as a rescue treatment for severe bronchopulmonary dysplasia and pulmonary arterial hypertension. SIL inhibits phosphodiesterase 6 (PDE6) as well as PDE5. Therefore, it is controversial as to whether SIL increases the risk of retinopathy of prematurity (ROP).

引用

页码：360 / 361

页数：2

共 4 条

[1] Childhood Nodal Marginal Zone Lymphoma with Unusual Clinicopathologic and Cytogenetic Features for the Pediatric Variant: A Case Report [J].